Jpmorgan Chase & CO Berkeley Lights, Inc. Transaction History

Jpmorgan Chase & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	N/A	-133,096 Reduced 90.9%	13,318 $10,000
Q2 2023 Aug 11, 2023	SELL	$0.79 - $1.23 $890,426 - $1.39 Million	-1,127,122 Reduced 88.5%	146,414 $118,000
Q1 2023 May 18, 2023	BUY	$1.04 - $2.77 $53,574 - $142,693	51,514 Added 4.22%	1,273,536 $1.48 Million
Q1 2023 May 11, 2023	SELL	$1.04 - $2.77 $176,563 - $470,271	-169,773 Reduced 12.2%	1,222,022 $1.42 Million
Q4 2022 Feb 13, 2023	SELL	$1.9 - $3.58 $429,920 - $810,060	-226,274 Reduced 13.98%	1,391,795 $3.73 Million
Q3 2022 Nov 14, 2022	BUY	$2.86 - $5.78 $698,094 - $1.41 Million	244,089 Added 17.77%	1,618,069 $4.63 Million
Q2 2022 Aug 11, 2022	BUY	$3.77 - $7.34 $897,489 - $1.75 Million	238,061 Added 20.96%	1,373,980 $6.83 Million
Q1 2022 May 11, 2022	SELL	$5.12 - $19.26 $3.07 Million - $11.5 Million	-599,111 Reduced 34.53%	1,135,919 $8.08 Million
Q4 2021 Feb 10, 2022	BUY	$17.39 - $25.74 $5.34 Million - $7.9 Million	306,859 Added 21.49%	1,735,030 $31.5 Million
Q3 2021 Nov 12, 2021	BUY	$19.5 - $50.03 $27.8 Million - $71.5 Million	1,428,171 New	1,428,171 $27.9 Million

2.22M

Ticker BLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,283,904
Market Cap $55.3M
Description
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and applic...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.